Clivatuzumab (biosimilar) Antibody from BIORBYT LTD.

Search, find, compare suppliers for anti-Clivatuzumab (biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityClivatuzumab (biosimilar)
Clonemonoclonal
Host SpeciesRecombinant
Reactive Speciesn/a
IsotypeIgG1 kappa
Formatpurified
Size5 mg, 1 mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionYttrium (90Y) clivatuzumab tetraxetan (trade name hPAM4-Cide) is a humanized monoclonal antibody-drug conjugate designed for the treatment of pancreatic cancer. The antibody part, clivatuzumab (targeted at MUC1), is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells.
Immunogenn/a
Other NameshPAM4, hPAM4 IgG-DOTA, hPAM4-DOTA
Gene, Accession #n/a
Catalog #orb1140941
Price$4317
Order / More InfoClivatuzumab (biosimilar) Antibody from BIORBYT LTD.
Product Specific Referencesn/a
BIORBYT LTD.
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240

info@biorbyt.com

http://www.biorbyt.com

U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558


Profile of BIORBYT LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.